Author:
Yuan Yujie,Huang Chunshuai,Singh Nilmani,Xun Guanhua,Zhao Huimin
Abstract
AbstractNatural products (NPs) produced by bacteria, fungi and plants are a major source of drug leads.Streptomycesspecies are particularly important in this regard as they produce numerous natural products with prominent bioactivities. Here we report a fullyautomated,scalable and high-throughput platform for discovery of bioactivenaturalproducts inStreptomyces(FAST-NPS). This platform comprises computational prediction and prioritization of target biosynthetic gene clusters (BGCs) guided by self-resistance genes, highly efficient and automated direct cloning and heterologous expression of BGCs, followed by high-throughput fermentation and product extraction fromStreptomycesstrains. As a proof of concept, we applied this platform to clone 105 BGCs ranging from 10 to 100 kb that contain potential self-resistance genes from 11Streptomycesstrains with a success rate of 95%. Heterologous expression of all successfully cloned BGCs inStreptomyces lividansTK24 led to the discovery of 23 natural products from 12 BGCs. We selected 5 of these 12 BGCs for further characterization and found each of them could produce at least one natural product with antibacterial and/or anti-tumor activity, which resulted in a total of 8 bioactive natural products. Overall, this work would greatly accelerate the discovery of bioactive natural products for biomedical and biotechnological applications.Graphic Abstracts
Publisher
Cold Spring Harbor Laboratory